Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host.
Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host. With the ever increasing new cancer cases across the globe and the conventional treatment methods unable to cope up with the challenges posed by the tumor and their immune response evading techniques, cancer immunotherapy brings a ray of hope.
The report details the trend, potential and market size of Peptide Cancer Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Peptide Cancer Vaccinemarket, defines the market attractiveness level of Peptide Cancer Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Peptide Cancer Vaccine industry, describes the types of Peptide Cancer Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Peptide Cancer Vaccine market and the development prospects and opportunities of Peptide Cancer Vaccine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Peptide Cancer Vaccine market in Chapter 13.
By Player:
VAXON Biotech
OncoTherapy Science
Generex Biotechnology
Ultimovacs
Sellas
Boston Biomedical
ISA Pharmaceuticals
TapImmune
Imugene
Immatics
BrightPath Biotherapeutics
By Type:
Goserelin
Bortezomib
Leuprorelin
Others
By End-User:
Breast Cancer
Lung Cancer
Melanoma
Prostate Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Peptide Cancer Vaccine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Peptide Cancer Vaccine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Peptide Cancer Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Peptide Cancer Vaccine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Peptide Cancer Vaccine Market Analysis and Outlook to 2022
-
7.1 Global Peptide Cancer Vaccine Consumption (2017-2022)
-
7.2 United States Peptide Cancer Vaccine Consumption (2017-2022)
-
7.3 Europe Peptide Cancer Vaccine Consumption (2017-2022)
-
7.4 China Peptide Cancer Vaccine Consumption (2017-2022)
-
7.5 Japan Peptide Cancer Vaccine Consumption (2017-2022)
-
7.6 India Peptide Cancer Vaccine Consumption (2017-2022)
-
7.7 South Korea Peptide Cancer Vaccine Consumption (2017-2022)
8 Region and Country-wise Peptide Cancer Vaccine Market Analysis and Outlook to 2028
-
8.1 Global Peptide Cancer Vaccine Consumption Forecast (2022-2028)
-
8.2 United States Peptide Cancer Vaccine Consumption Forecast (2022-2028)
-
8.3 Europe Peptide Cancer Vaccine Consumption Forecast (2022-2028)
-
8.4 China Peptide Cancer Vaccine Consumption Forecast (2022-2028)
-
8.5 Japan Peptide Cancer Vaccine Consumption Forecast (2022-2028)
-
8.6 India Peptide Cancer Vaccine Consumption Forecast (2022-2028)
-
8.7 South Korea Peptide Cancer Vaccine Consumption Forecast (2022-2028)
9 Global Peptide Cancer Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global Peptide Cancer Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Goserelin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Bortezomib Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Leuprorelin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Peptide Cancer Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Melanoma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Peptide Cancer Vaccine Market Outlook by Types and Applications to 2028
-
10.1 Global Peptide Cancer Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Goserelin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Bortezomib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Leuprorelin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Peptide Cancer Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Peptide Cancer Vaccine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Peptide Cancer Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Peptide Cancer Vaccine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Peptide Cancer Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Peptide Cancer Vaccine Market Competitive Analysis
-
14.1 VAXON Biotech
-
14.1.1 VAXON Biotech Company Details
-
14.1.2 VAXON Biotech Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 VAXON Biotech Peptide Cancer Vaccine Product and Service
-
14.2 OncoTherapy Science
-
14.2.1 OncoTherapy Science Company Details
-
14.2.2 OncoTherapy Science Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 OncoTherapy Science Peptide Cancer Vaccine Product and Service
-
14.3 Generex Biotechnology
-
14.3.1 Generex Biotechnology Company Details
-
14.3.2 Generex Biotechnology Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Generex Biotechnology Peptide Cancer Vaccine Product and Service
-
14.4 Ultimovacs
-
14.4.1 Ultimovacs Company Details
-
14.4.2 Ultimovacs Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Ultimovacs Peptide Cancer Vaccine Product and Service
-
14.5 Sellas
-
14.5.1 Sellas Company Details
-
14.5.2 Sellas Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sellas Peptide Cancer Vaccine Product and Service
-
14.6 Boston Biomedical
-
14.6.1 Boston Biomedical Company Details
-
14.6.2 Boston Biomedical Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Boston Biomedical Peptide Cancer Vaccine Product and Service
-
14.7 ISA Pharmaceuticals
-
14.7.1 ISA Pharmaceuticals Company Details
-
14.7.2 ISA Pharmaceuticals Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 ISA Pharmaceuticals Peptide Cancer Vaccine Product and Service
-
14.8 TapImmune
-
14.8.1 TapImmune Company Details
-
14.8.2 TapImmune Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 TapImmune Peptide Cancer Vaccine Product and Service
-
14.9 Imugene
-
14.9.1 Imugene Company Details
-
14.9.2 Imugene Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Imugene Peptide Cancer Vaccine Product and Service
-
14.10 Immatics
-
14.10.1 Immatics Company Details
-
14.10.2 Immatics Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Immatics Peptide Cancer Vaccine Product and Service
-
14.11 BrightPath Biotherapeutics
-
14.11.1 BrightPath Biotherapeutics Company Details
-
14.11.2 BrightPath Biotherapeutics Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 BrightPath Biotherapeutics Peptide Cancer Vaccine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Peptide Cancer Vaccine
-
Figure Peptide Cancer Vaccine Picture
-
Table Global Peptide Cancer Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide Cancer Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide Cancer Vaccine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Peptide Cancer Vaccine Consumption by Country (2017-2022)
-
Figure United States Peptide Cancer Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe Peptide Cancer Vaccine Consumption and Growth Rate (2017-2022)
-
Figure China Peptide Cancer Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan Peptide Cancer Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India Peptide Cancer Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Peptide Cancer Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Peptide Cancer Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States Peptide Cancer Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Peptide Cancer Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Peptide Cancer Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Peptide Cancer Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Peptide Cancer Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Peptide Cancer Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Goserelin Consumption and Growth Rate (2017-2022)
-
Figure Global Bortezomib Consumption and Growth Rate (2017-2022)
-
Figure Global Leuprorelin Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Goserelin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bortezomib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Leuprorelin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Peptide Cancer Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Peptide Cancer Vaccine Export by Region (Top 5 Countries) (2017-2028)
-
Table VAXON Biotech (Foundation Year, Company Profile and etc.)
-
Table VAXON Biotech Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table VAXON Biotech Peptide Cancer Vaccine Product and Service
-
Table OncoTherapy Science (Foundation Year, Company Profile and etc.)
-
Table OncoTherapy Science Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table OncoTherapy Science Peptide Cancer Vaccine Product and Service
-
Table Generex Biotechnology (Foundation Year, Company Profile and etc.)
-
Table Generex Biotechnology Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Generex Biotechnology Peptide Cancer Vaccine Product and Service
-
Table Ultimovacs (Foundation Year, Company Profile and etc.)
-
Table Ultimovacs Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ultimovacs Peptide Cancer Vaccine Product and Service
-
Table Sellas (Foundation Year, Company Profile and etc.)
-
Table Sellas Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sellas Peptide Cancer Vaccine Product and Service
-
Table Boston Biomedical (Foundation Year, Company Profile and etc.)
-
Table Boston Biomedical Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boston Biomedical Peptide Cancer Vaccine Product and Service
-
Table ISA Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table ISA Pharmaceuticals Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table ISA Pharmaceuticals Peptide Cancer Vaccine Product and Service
-
Table TapImmune (Foundation Year, Company Profile and etc.)
-
Table TapImmune Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table TapImmune Peptide Cancer Vaccine Product and Service
-
Table Imugene (Foundation Year, Company Profile and etc.)
-
Table Imugene Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Imugene Peptide Cancer Vaccine Product and Service
-
Table Immatics (Foundation Year, Company Profile and etc.)
-
Table Immatics Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Immatics Peptide Cancer Vaccine Product and Service
-
Table BrightPath Biotherapeutics (Foundation Year, Company Profile and etc.)
-
Table BrightPath Biotherapeutics Peptide Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table BrightPath Biotherapeutics Peptide Cancer Vaccine Product and Service
-
